COVIDMS

Focalpage
Dec 30, 2021

Humoral and cellular immune responses to SARS CoV-2 vaccination in Persons with Multiple Sclerosis and NMOSD patients receiving immunomodulatory treatments Bock, H., Juretzek, T., Handreka, R., Ruhnau, J., Reuner, K., Peltroche, H., Dressel, A. MedRXiv 10.1101/2021.12.22.21268127 Background: Vaccination against SARS CoV-2 results in excellent personal protection against a severe course of COVID19. In persons with Multiple […]

--

--